Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucas R Hoffman

Showing results (11-20 of 112) with videos related to

Pageof 12
Sort By:
Cell Host & Microbe|November 17, 2007
Did bacterial sensing of host environments evolve from sensing within microbial communities?Samuel I Miller, Lucas R Hoffman, Sarah Sanowar
Antimicrobial Agents and Chemotherapy|April 21, 2010
Exploratory study of the prevalence and clinical significance of tobramycin-mediated biofilm induction in Pseudomonas aeruginosa isolates from cystic fibrosis patientsDanielle Elliott, Jane L Burns, Lucas R Hoffman
Current Opinion in Pulmonary Medicine|August 9, 2017
How can the cystic fibrosis respiratory microbiome influence our clinical decision-making?Geraint B Rogers, Kenneth D Bruce, Lucas R Hoffman
Pediatric Research|July 23, 2019
Making the case for ACEs: adverse childhood experiences, obesity, and long-term healthJoyce R Javier, Lucas R Hoffman, Shetal I Shah, et al.
Pediatric Pulmonology|September 24, 2016
The CF gastrointestinal microbiome: Structure and clinical impactGeraint B Rogers, Michael R Narkewicz, Lucas R Hoffman
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 9, 2021
Phenotypic characteristics of incident and chronic MRSA isolates in cystic fibrosisDeirdre Gilpin, Lucas R Hoffman, Agathe Ceppe, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|August 17, 2019
The impact of CFTR modulator therapies on CF airway microbiologyGeraint B Rogers, Steven L Taylor, Lucas R Hoffman, et al.
Trends in Microbiology|April 20, 2013
Interpreting infective microbiota: the importance of an ecological perspectiveGeraint B Rogers, Lucas R Hoffman, Mary P Carroll, et al.
Expert Opinion on Emerging Drugs|March 5, 2015
Emerging drugs for bronchiectasis: an updateAnne B Chang, Robyn L Marsh, Heidi C Smith-Vaughan, et al.
Expert Opinion on Emerging Drugs|July 20, 2012
Emerging drugs for bronchiectasisAnne B Chang, Robyn L Marsh, Heidi C Smith-Vaughan, et al.
Pageof 12

Showing results (11-20 of 112) with videos related to

Sort By:
Pageof 12
Cell Host & Microbe|November 17, 2007
Did bacterial sensing of host environments evolve from sensing within microbial communities?Samuel I Miller, Lucas R Hoffman, Sarah Sanowar
Antimicrobial Agents and Chemotherapy|April 21, 2010
Exploratory study of the prevalence and clinical significance of tobramycin-mediated biofilm induction in Pseudomonas aeruginosa isolates from cystic fibrosis patientsDanielle Elliott, Jane L Burns, Lucas R Hoffman
Current Opinion in Pulmonary Medicine|August 9, 2017
How can the cystic fibrosis respiratory microbiome influence our clinical decision-making?Geraint B Rogers, Kenneth D Bruce, Lucas R Hoffman
Pediatric Research|July 23, 2019
Making the case for ACEs: adverse childhood experiences, obesity, and long-term healthJoyce R Javier, Lucas R Hoffman, Shetal I Shah, et al.
Pediatric Pulmonology|September 24, 2016
The CF gastrointestinal microbiome: Structure and clinical impactGeraint B Rogers, Michael R Narkewicz, Lucas R Hoffman
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 9, 2021
Phenotypic characteristics of incident and chronic MRSA isolates in cystic fibrosisDeirdre Gilpin, Lucas R Hoffman, Agathe Ceppe, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|August 17, 2019
The impact of CFTR modulator therapies on CF airway microbiologyGeraint B Rogers, Steven L Taylor, Lucas R Hoffman, et al.
Trends in Microbiology|April 20, 2013
Interpreting infective microbiota: the importance of an ecological perspectiveGeraint B Rogers, Lucas R Hoffman, Mary P Carroll, et al.
Expert Opinion on Emerging Drugs|March 5, 2015
Emerging drugs for bronchiectasis: an updateAnne B Chang, Robyn L Marsh, Heidi C Smith-Vaughan, et al.
Expert Opinion on Emerging Drugs|July 20, 2012
Emerging drugs for bronchiectasisAnne B Chang, Robyn L Marsh, Heidi C Smith-Vaughan, et al.
Pageof 12